 |
||||
| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
CLINICAL SCIENCE |
*Section of Nephrology, Department of Medicine, and Biostatistics, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway.
Correspondence to Dr. Jøran Hjelmesæth, Department of Medicine, The Hospital in Vestfold HF, Boks 2168, 3103 Tønsberg, Norway. Phone: +47 40 21 73 49; Fax: +47 33 34 39 38; E-mail: joran{at}online.no
Cardiovascular disease is a prevalent and serious complication after solid organ transplantation. Treatment with glucocorticoids is associated with increased risk for diabetes mellitus, insulin resistance, weight gain, hypercholesterolemia, and hypertension, all shown to be independent risk factors for cardiovascular disease. We sought to test the hypothesis that tapering of prednisolone (TAP) the first year after renal transplantation improves insulin sensitivity (IS), and to assess the effect of complete steroid withdrawal (SW) on IS in patients on a cyclosporine-based immunosuppressive regimen. All patients (n = 57) completed two consecutive hyperinsulinemic euglycemic glucose clamp procedures, a TAP group (n = 34) and a control group (n = 12) at 3 and 12 mo after transplantation, and a SW group (n = 11) before and 5 mo after SW. The IS index (ISI) was calculated as the glucose disposal rate divided by mean serum insulin the last 60 min of the clamp. In the TAP group, the mean (range) daily prednisolone was reduced from 16 (10 to 30) to 9 (5 to 12.5) mg accompanied by an average increased ISI of 24% (P = 0.008). In contrast, no significant change in ISI was observed in the control group (0%, P = 0.988). In the SW group, withdrawal of 5 mg prednisolone did not influence mean ISI significantly (–8%, P = 0.206). Lowering daily prednisolone toward 5 mg/d has beneficial effects on insulin action after renal transplantation, but withdrawal of 5 mg prednisolone may not influence IS significantly.
This article has been cited by other articles:
 |
|
 |
|
  H. A. Bergrem, T. G. Valderhaug, A. Hartmann, H. Bergrem, J. Hjelmesaeth, and T. Jenssen Glucose tolerance before and after renal transplantation Nephrol. Dial. Transplant., October 23, 2009; (2009) gfp566v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chadban New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1816 - 1818. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Shirali and M. J. Bia Management of Cardiovascular Disease in Renal Transplant Recipients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Bloom and M. F. Crutchlow New-Onset Diabetes Mellitus in the Kidney Recipient: Diagnosis and Management Strategies Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S38 - S48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J N Hoes, J W G Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, E H Choy, M Cutolo, J A P Da Silva, G Esselens, et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases Ann Rheum Dis, December 1, 2007; 66(12): 1560 - 1567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aoun, P. Eschewege, Y. Hamoudi, S. Beaudreuil, J. Duranteau, G. Cheisson, C. Noel, G. Benoit, B. Charpentier, and A. Durrbach Very early steroid withdrawal in simultaneous pancreas-kidney transplants Nephrol. Dial. Transplant., March 1, 2007; 22(3): 899 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rodrigo, G. Fernandez-Fresnedo, R. Valero, J. C. Ruiz, C. Pinera, R. Palomar, J. Gonzalez-Cotorruelo, C. Gomez-Alamillo, and M. Arias New-Onset Diabetes after Kidney Transplantation: Risk Factors J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S291 - S295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Augustine and D. E. Hricik Steroid Sparing in Kidney Transplantation: Changing Paradigms, Improving Outcomes, and Remaining Questions Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1080 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hjelmesaeth, A. Flyvbjerg, T. Jenssen, J. Frystyk, T. Ueland, M. Hagen, and A. Hartmann Hypoadiponectinemia Is Associated with Insulin Resistance and Glucose Intolerance after Renal Transplantation: Impact of Immunosuppressive and Antihypertensive Drug Therapy Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 575 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Oterdoom, A. P.J. de Vries, W. J. van Son, J. J. H. van der Heide, R. J. Ploeg, R. T. Gansevoort, P. E. de Jong, R. O.B. Gans, and S. J.L. Bakker Validation of Insulin Resistance Indexes in a Stable Renal Transplant Population Diabetes Care, October 1, 2005; 28(10): 2424 - 2429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Teutonico, P. F. Schena, and S. Di Paolo Glucose Metabolism in Renal Transplant Recipients: Effect of Calcineurin Inhibitor Withdrawal and Conversion to Sirolimus J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3128 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Voytovich, C. Simonsen, T. Jenssen, J. Hjelmesaeth, A. Asberg, and A. Hartmann Reply Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1512 - 1512. [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
